- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 3.89 Å
- Oligo State
- hetero-3-3-2-2-mer
- Ligands
- 4 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA.2: 7 residues within 4Å:- Chain A: N.165, T.167, I.242, L.244
- Chain E: Y.219, R.222, N.225
2 PLIP interactions:1 interactions with chain E, 1 interactions with chain A- Hydrogen bonds: E:R.222, E:R.222, E:N.225
- Hydrophobic interactions: A:I.242
NAG-NAG-BMA.5: 9 residues within 4Å:- Chain A: Y.219, P.221, R.222, N.225
- Chain B: N.165, T.167, L.244
- Ligands: NAG-NAG.4, NAG-NAG.4
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:R.222, A:R.222, A:R.222, A:N.225
NAG-NAG-BMA.7: 6 residues within 4Å:- Chain B: Y.219, P.221, R.222
- Chain E: N.165, T.167, L.244
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:R.222, B:R.222
- 20 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.8: 2 residues within 4Å:- Chain A: N.285, V.297
Ligand excluded by PLIPNAG.9: 3 residues within 4Å:- Chain A: N.122, N.133, R.255
Ligand excluded by PLIPNAG.10: 1 residues within 4Å:- Chain A: N.22
Ligand excluded by PLIPNAG.11: 2 residues within 4Å:- Chain A: N.38
- Chain C: W.21
Ligand excluded by PLIPNAG.12: 3 residues within 4Å:- Chain A: E.62, N.63, Y.94
Ligand excluded by PLIPNAG.13: 3 residues within 4Å:- Chain B: N.285, V.297, N.298
Ligand excluded by PLIPNAG.14: 3 residues within 4Å:- Chain B: Q.132, N.133, R.255
Ligand excluded by PLIPNAG.15: 1 residues within 4Å:- Chain B: N.22
Ligand excluded by PLIPNAG.16: 2 residues within 4Å:- Chain B: N.38, A.39
Ligand excluded by PLIPNAG.17: 3 residues within 4Å:- Chain B: E.62, N.63, Y.94
Ligand excluded by PLIPNAG.18: 1 residues within 4Å:- Chain B: N.126
Ligand excluded by PLIPNAG.19: 2 residues within 4Å:- Chain C: G.150, N.154
Ligand excluded by PLIPNAG.20: 4 residues within 4Å:- Chain D: A.147, G.150, S.151, N.154
Ligand excluded by PLIPNAG.21: 2 residues within 4Å:- Chain E: N.285, V.297
Ligand excluded by PLIPNAG.22: 2 residues within 4Å:- Chain E: N.133, R.255
Ligand excluded by PLIPNAG.23: 1 residues within 4Å:- Chain E: N.22
Ligand excluded by PLIPNAG.24: 3 residues within 4Å:- Chain E: N.38, T.40, T.318
Ligand excluded by PLIPNAG.25: 3 residues within 4Å:- Chain E: E.62, N.63, Y.94
Ligand excluded by PLIPNAG.26: 1 residues within 4Å:- Chain E: N.126
Ligand excluded by PLIPNAG.27: 2 residues within 4Å:- Chain F: G.150, N.154
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Rawi, R. et al., The N terminus of H3-influenza hemagglutinin as a site-of-vulnerability to neutralizing antibody. Structure (2025)
- Release Date
- 2025-07-16
- Peptides
- Hemagglutinin HA1: ABE
Hemagglutinin HA2: CDF
5E10 Fab Heavy chain: GI
5E10 Fab Light chain: HJ - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
BB
CE
GC
ED
FF
IG
AI
HH
DJ
J
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 3.89 Å
- Oligo State
- hetero-3-3-2-2-mer
- Ligands
- 4 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 20 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Rawi, R. et al., The N terminus of H3-influenza hemagglutinin as a site-of-vulnerability to neutralizing antibody. Structure (2025)
- Release Date
- 2025-07-16
- Peptides
- Hemagglutinin HA1: ABE
Hemagglutinin HA2: CDF
5E10 Fab Heavy chain: GI
5E10 Fab Light chain: HJ - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
BB
CE
GC
ED
FF
IG
AI
HH
DJ
J